You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DYN Sale Disclosure
Rhodes Jason P · SEC Form 4 · Filed Jun 30, 2026
Sale
Calculated transaction value
$2.18M
Rhodes Jason P Director
DYN
Transaction date
Jun 29, 2026
Public filing date
Jun 30, 2026
Filing lag
Filed 1 day later
DYN daily price context
Close on/before transaction
$21.26
Jun 29, 2026
First close after public filing
$21.79
Jul 1, 2026
30-day return after filing
+18.08%
Through Jul 30, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 102,969 shares @ $21.14
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001577014-26-000012
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$10.71M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Dyne Therapeutics, Inc. DYN Current | Sale | Jun 29, 2026 | $2.18M |
| Dyne Therapeutics, Inc. DYN | Sale | Jun 29, 2026 | $1.09M |
| Dyne Therapeutics, Inc. DYN | Sale | Jun 29, 2026 | $860.44K |
| Dyne Therapeutics, Inc. DYN | Sale | Jun 26, 2026 | $3.47M |
| Dyne Therapeutics, Inc. DYN | Sale | Jun 26, 2026 | $1.74M |
| Dyne Therapeutics, Inc. DYN | Sale | Jun 26, 2026 | $1.37M |